COVID-19 Clinical Trials: A Teachable Moment for Improving Our Research Infrastructure and Relevance
- PMID: 32543881
- PMCID: PMC7322771
- DOI: 10.7326/M20-2959
COVID-19 Clinical Trials: A Teachable Moment for Improving Our Research Infrastructure and Relevance
Abstract
The authors posit the need for rapid evaluation of therapies for COVID-19 as an inflection point spurring a much-needed rethinking of our research enterprise.
References
-
- Institute of Medicine. Envisioning a Transformed Clinical Trials Enterprise in the United States: Establishing an Agenda for 2020: Workshop Summary. National Academies Pr; 2012. - PubMed
-
- Institute of Medicine. Transforming Clinical Research in the United States: Challenges and Opportunities: Workshop Summary. National Academies Pr; 2010. - PubMed
-
- Woodcock J, LaVange LM. Master protocols to study multiple therapies, multiple diseases, or both. N Engl J Med. 2017;377:62-70. [PMID: 28679092] doi:10.1056/NEJMra1510062. - PubMed
-
- Marin M. COVID-19 clinical trials explorer. Accessed at https://public.tableau.com/profile/marinamarin#!/vizhome/covidTrials/COV.... on 2 June 2020.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical